EMA Authorised: Vfend (voriconazole) — Pfizer Europe MA EEIG

View source ↗

Summary

The European Medicines Agency authorised Vfend (voriconazole) for fungal infections including candidiasis and aspergillosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspergillosis
• Candidiasis

Drugs mentioned

• VFEND (Voriconazole)

Snippet

Status: Authorised. Therapeutic area: Candidiasis;Mycoses;Aspergillosis. MAH: Pfizer Europe MA EEIG. Decision date: 10/02/2026